Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 506 across all filing types
Latest filing 2021-11-04 Declaration of Voting R…
Country FR France
Listing Euronext Growth ALEUP

About Europlasma

https://www.europlasma.com/en/

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Information relative au nombre total de droits de vote et d'actions composant le capital au 31 octobre 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated November 4, 2021, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 31 octobre 2021" (Information relating to the total number of voting rights and shares comprising the capital as of October 31, 2021). It explicitly states it is in compliance with French commercial code (L. 233-8 II) and AMF regulations (223-16), detailing the total number of shares and voting rights. This type of mandatory periodic disclosure regarding capital structure changes or status updates, especially when related to voting rights, often falls under general regulatory announcements or specific share/capital change notifications. Since it is a notification about the total number of shares and voting rights, it most closely aligns with 'Share Issue/Capital Change' (SHA) or, given its nature as a mandatory regulatory disclosure not fitting perfectly elsewhere, potentially 'Regulatory Filings' (RNS). However, the core content is a direct report on the capital structure (shares and voting rights), making SHA the most specific fit among the options, although it is not a direct issuance or repurchase announcement, but a status report. Given the options, and recognizing this is a mandatory disclosure of share count/voting rights, SHA is the best fit, though RNS is a strong secondary candidate if SHA is interpreted strictly as issuance/repurchase. Since the document reports the current state of shares and voting rights, which is a fundamental aspect of capital structure, I will classify it as SHA.
2021-11-04 French
EUROPLASMA: Mise à disposition du Rapport Financier Semestriel 2021
Report Publication Announcement Classification · 98% confidence The document is a press release dated October 28, 2021, titled "Mise à disposition du Rapport Financier Semestriel 2021" (Making available of the 2021 Half-Year Financial Report). It explicitly states that the company has put its half-year financial report online and that it is available for consultation and download. The document itself is short (under 3,000 characters) and serves to announce the publication of the actual report, rather than being the comprehensive report itself. This aligns perfectly with the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports. The content is not the full Interim Report (IR) but the notice of its availability.
2021-10-28 French
Rapport Financier Semestriel 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Rapport financier semestriel' (Semi-annual financial report) for the period ending June 30, 2021. It contains comprehensive financial statements, including the consolidated balance sheet, income statement, cash flow statement, and notes to the accounts. It is a full interim report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H2 2021
2021-10-28 French
EUROPLASMA: Résultats du premier semestre 2021 : Poursuite de la relance industrielle et commerciale et mise en place de la 2ème phase du plan stratégique
Earnings Release Classification · 100% confidence The document is explicitly titled "Résultats du premier semestre 2021" (First Half 2021 Results) and presents detailed financial tables comparing H1 2021 results (ending June 30, 2021) against H1 2020, along with management commentary on performance and outlook. This structure and content clearly indicate a comprehensive financial report covering a period shorter than a full year. This aligns perfectly with the definition of an Interim / Quarterly Report (Code: IR). It is not an Earnings Release (ER) because it is a detailed report, not just the initial highlights, and it is not a 10-K as it covers only six months. H1 2021
2021-10-27 French
EUROPLASMA : Visite de Madame Florence PARLY, ministre des Armées, sur le site des Forges de Tarbes
Regulatory Filings Classification · 95% confidence The document is a press release detailing a visit by the French Minister of the Armed Forces to the Forges de Tarbes site, which was recently acquired by Europlasma. It discusses government support, future investment (€10 million), and the strategic importance of the site for defense manufacturing. This type of announcement, focusing on operational news, government interaction, and strategic direction rather than mandatory financial reporting (like 10-K, ER, or IR), fits best under a general regulatory or corporate announcement category. Since it is not a specific financial report, management change, dividend notice, or shareholder vote result, and it is a formal communication about a significant corporate/industrial event, it is classified as a general Regulatory Filing (RNS) as the most appropriate fallback, although it functions like a press release.
2021-10-12 French
EUROPLASMA: Information relative au nombre total de droits de vote et d'actions composant le capital au 30 septembre 2021
Share Issue/Capital Change Classification · 95% confidence The document is a press release dated October 4, 2021, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 30 septembre 2021" (Information relative to the total number of voting rights and shares comprising the capital as of September 30, 2021). It explicitly states the total number of shares and voting rights, referencing French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of mandatory disclosure regarding the total number of shares and voting rights is typically classified as a Major Shareholding Notification or a general regulatory filing concerning capital structure changes, but given the specific nature of reporting the total share count as required by market authorities, it aligns best with 'Major Shareholding Notification' (MRQ) or potentially a general regulatory filing (RNS). Since it is a mandatory disclosure about the capital structure's current state (total shares/votes), and not a transaction (POS) or a general capital change (SHA), MRQ is the most fitting specific category for mandatory capital structure updates that aren't dividend or share issuance announcements. However, since the definition for MRQ is 'Notification of changes in significant share ownership levels (crossing thresholds)', and this document reports the *total* count as of a specific date, it is a fundamental capital structure disclosure. Given the options, and the fact that it is a mandatory disclosure about the capital base, it is closest to a general regulatory filing (RNS) or a capital structure update. Let's re-evaluate the definitions. It is not a dividend (DIV), not a share issue (SHA/POS), and not a management change (MANG). It is a mandatory regulatory disclosure about the capital base. In many contexts, this specific type of filing (total voting rights disclosure) falls under general regulatory announcements. Given the available codes, RNS (Regulatory Filings - fallback) is appropriate if MRQ doesn't strictly apply, but MRQ often covers any filing related to share capital structure reporting. Since the document reports the total number of shares and voting rights, which is a key metric often reported alongside major shareholding changes, I will classify it as MRQ as it pertains directly to the composition of the share capital base, or RNS if MRQ is too narrow. Given the context of French regulations requiring this specific disclosure, it is a mandatory regulatory filing. I will select RNS as the most robust fallback for mandatory, non-transactional capital structure reporting that doesn't fit other specific codes perfectly, although it is very close to the spirit of MRQ. Upon review, this specific filing type (total voting rights) is often grouped with MRQ or RNS. I will choose RNS as the general regulatory filing category for this mandatory disclosure.
2021-10-04 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.